Hany Massarany - 20 May 2021 Form 4 Insider Report for Accelerate Diagnostics, Inc (AXDX)

Role
Director
Signature
/s/ Steven Reichling, attorney-in-fact
Issuer symbol
AXDX
Transactions as of
20 May 2021
Net transactions value
$0
Form type
4
Filing time
24 May 2021, 21:59:45 UTC
Next filing
01 Jul 2021
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AXDX Stock Option (right to buy) Award $0 +93,783 $0.000000 93,783 20 May 2021 Common Stock 93,783 $7.68 Direct F1
transaction AXDX Stock Option (right to buy) Award $0 +31,261 $0.000000 31,261 20 May 2021 Common Stock 31,261 $7.68 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests in five equal annual installments beginning on May 20, 2022.
F2 The option vests in full on May 20, 2022.